Market Overview

The Global Dermatological Therapeutics Market was valued at USD 52,647.9 million in 2023 and is expected to reach USD 113,678.9 million by 2031 while growing at a CAGR of 10.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global dermatological therapeutics market growth. Dermatological therapeutics refers to the branch of medicine focused on the diagnosis, treatment, and management of skin disorders and conditions. This field encompasses a wide range of therapies, including topical medications, oral medications, phototherapy, surgical interventions, and various procedures aimed at addressing dermatological issues such as acne, eczema, psoriasis, skin cancer, infections, allergic reactions, and other dermatological conditions.

The growth of the market is driven by the increasing prevalence of skin disorders, the growing aging population, and rising awareness and education. However, stringent regulatory requirements and high treatment costs act as hindrances to market growth.

Furthermore, the global dermatological therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Application Analysis

The Global Dermatological Therapeutics Market is segmented among Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications, based on Application. In 2023, Psoriasis accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Drug Class Analysis

The Global Dermatological Therapeutics Market is segmented among Anti-infective, Corticosteroids, Anti-Acne, Calcineurin Inhibitors, Retinoids, and Other Drug Class, based on Drug Class. In 2023, Anti-infective accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Dermatological Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbvie Inc. (Allergan PLC), Almirall SA, Amgen Inc., Bausch Health Companies Inc., Galderma SA, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, LEO Pharma AS, Eli Lilly and Company, Sun Pharmaceuticals Ltd, Aclaris Therapeutics Inc., Aurobindo Pharma Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Dermatological Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Dermatological Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Dermatological Therapeutics Market Segmentation, By Application

• Global Dermatological Therapeutics Market Share Analysis, By Application

• Global Dermatological Therapeutics Market Growth Analysis, By Application

• Global Dermatological Therapeutics Market Trends, By Application

o Alopecia

o Herpes

o Psoriasis

o Rosacea

o Atopic Dermatitis

o Other Applications

6. Global Dermatological Therapeutics Market Segmentation, By Drug Class

• Global Dermatological Therapeutics Market Share Analysis, By Drug Class

• Global Dermatological Therapeutics Market Growth Analysis, By Drug Class

• Global Dermatological Therapeutics Market Trends, By Drug Class

o Anti-infective

o Corticosteroids

o Anti-Acne

o Calcineurin Inhibitors

o Retinoids

o Other Drug Class

7. Global Dermatological Therapeutics Market Segmentation, By Region

• Global Dermatological Therapeutics Market Share Analysis, By Region

• Global Dermatological Therapeutics Market Growth Analysis, By Region

• Global Dermatological Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbvie Inc. (Allergan PLC)*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Almirall SA

• Amgen Inc.

• Bausch Health Companies Inc.

• Galderma SA

• GlaxoSmithKline PLC

• Johnson & Johnson

• Novartis AG

• Pfizer Inc.

• Bristol-Myers Squibb Company

• LEO Pharma AS

• Eli Lilly and Company

• Sun Pharmaceuticals Ltd

• Aclaris Therapeutics Inc.

• Aurobindo Pharma Ltd

*Similar analysis will be provided for each company listed above.